Stay updated with breaking news from Tom Petzinger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pittsburgh Community Broadcasting Corporation adds three members to its Board and elects Tom Petzinger to serve a third and final term… Former President Trump appears on North Dakota radio station…
Knopp Biosciences LLC today announced that it was awarded a third year of research funding by the National Institutes of Health (NIH) to advance the development of its novel non-opioid therapies for
(0) Poster presentation will describe effects of dexpramipexole on blood absolute eosinophil count, lung function, and safety Knopp Biosciences LLC today announced it will present detailed results of its positive Phase 2 dose-ranging EXHALE trial of the novel oral eosinophil-lowering drug dexpramipexole in patients with moderate-to-severe asthma in a virtual poster session at the ATS 2021 International Conference. "We look forward to sharing comprehensive results of the EXHALE trial, which underscore the readiness of dexpramipexole for further development in eosinophilic asthma," said Michael...
Knopp Biosciences LLC: Knopp Biosciences Announces Positive Top-Line Results from the Phase 2 EXHALE Trial of Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma Reduction in blood eosinophil count correlated with clinically important improvement in lung function Knopp Biosciences LLC today announced positive top-line results in a Phase 2 dose-ranging trial of the novel oral drug dexpramipexole in patients with moderate-to-severe eosinophilic asthma. The EXHALE study met its primary endpoint, with dexpramipexole demonstrating a statistically significant, dose-dependent reduction in ...